Experiment 510311

Compounds isolated

Details

PropertyValue
Pharmacology
OrganismEmpty organism
CitationSCHEID,C: PRENDIVILLE,J: JAYSON,G: CROWTHER,D: FOX,B: PETTIT,GR: STERN,PL:. (1994). IMMUNOMODULATION IN PATIENTS RECEIVING INTRAVENOUS BRYOSTATIN 1 IN A PHASE I CLINICAL STUDY: COMPARISON WITH EFFECTS OF BRYOSTATIN 1 ON LYMPHOCYTE FUNCTION IN VITRO.. 39(4)
Amount utilized
Compound isolated
DiseaseHUMAN PERIPHERAL LYMPHOCYTES EXPOSED TO CMPD EXHIBITED IL-2-INDUCED PROLIFERATION BUT DECREASED IL-2-INDUCED CYTOTOXICITY.
Dose amount10.0 NANOMOLS
Number4
Qualitative resultACTIVE
AnimalCELL CULTURE
Dose expressionCONC USED